Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Reexamination Certificate
2007-06-26
2007-06-26
Kishore, Gollamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
C424S435000, C424S450000, C514S011400, C514S937000, C514S938000
Reexamination Certificate
active
10263164
ABSTRACT:
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva]2-Ciclosporin, in “microemulsion pre-concentrate” and microemulsion form. The compositions typically comprise (1.1) a C1-5alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
REFERENCES:
patent: 3288824 (1966-11-01), Mahler et al.
patent: 3813345 (1974-05-01), Urton
patent: 3954967 (1976-05-01), Urton
patent: 4073943 (1978-02-01), Wretlind et al.
patent: 4146499 (1979-03-01), Rosano
patent: 4156719 (1979-05-01), Sezaki et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4567161 (1986-01-01), Posanski et al.
patent: 4605422 (1986-08-01), Goddard et al.
patent: 4695450 (1987-09-01), Bauer et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4794000 (1988-12-01), Ecanow
patent: 4797272 (1989-01-01), Linn et al.
patent: 4797273 (1989-01-01), Linn et al.
patent: 4798823 (1989-01-01), Witzel
patent: 4835002 (1989-05-01), Wolf et al.
patent: 4888239 (1989-12-01), Brox
patent: 4914188 (1990-04-01), Dumont et al.
patent: 4963367 (1990-10-01), Ecanow
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5037653 (1991-08-01), Dawson
patent: 5047396 (1991-09-01), Orban et al.
patent: 5154754 (1992-10-01), Damo et al.
patent: 5342625 (1994-08-01), Hauer
patent: 5525590 (1996-06-01), Bollinger et al.
patent: 5639724 (1997-06-01), Cavanak
patent: 5741512 (1998-04-01), Hauer
patent: 5756450 (1998-05-01), Hahn et al.
patent: 5866159 (1999-02-01), Hauer
patent: 5916589 (1999-06-01), Hauer
patent: 5962017 (1999-10-01), Hauer
patent: 8770043 (1987-02-01), None
patent: 895724 (1983-07-01), None
patent: 1209361 (1986-08-01), None
patent: 2461786 (1983-06-01), None
patent: 8634788 (1983-06-01), None
patent: 641356 (1984-02-01), None
patent: 3315805 (1984-11-01), None
patent: 135171 (1985-03-01), None
patent: 170623 (1986-02-01), None
patent: 211258 (1987-02-01), None
patent: 256856 (1988-02-01), None
patent: 274431 (1988-07-01), None
patent: 0 315 079 (1989-05-01), None
patent: 314689 (1989-05-01), None
patent: 2553661 (1985-04-01), None
patent: 1171125 (1969-11-01), None
patent: 2098865 (1982-12-01), None
patent: 2206119 (1988-12-01), None
patent: 2209671 (1989-05-01), None
patent: 2 211 408 (1989-07-01), None
patent: 2211848 (1989-07-01), None
patent: 024776 (1985-04-01), None
patent: 280435 (1985-04-01), None
patent: 249918 (1986-07-01), None
patent: 61280435 (1986-12-01), None
patent: 8602264 (1986-04-01), None
patent: 8701035 (1987-02-01), None
patent: 8800059 (1988-01-01), None
patent: WO 93/20833 (1993-10-01), None
Anon., 95:225610K (1981).
Anon., Research Disclosure 21143 (Nov. 1981).
Beyer, et al., Phamazie in unserer Zeit, vol. 12(2):55-60 (1983).
Bhargava, et al., Pharm. Technol. (Mar. 1987).
Cavanak and Sucker, Prog. Allergy, vol. 38:65-72 (1986).
Ekman S., Lipids, 22:657-663 (1987).
Ritschel, et al., Pharm. Res., vol. 5(10): Suppl. 108 (1988).
Stupar, et al., Goldschmidt Inforwist Essein., vol. 52:22-28 (1982) (translation).
Takada, 87-024776/04 (Apr. 4, 1985).
Hahn, Biodegradable Tensides (1988) (translation).
Jayakrishnan, et al., J. Soc. Cosmet. Chem., 34:335-350 (1983).
Mizushima, 86-335072/51 (Jul. 26, 1985).
Mubarak, Development and Testing of New Microemulsions (1982) (translation).
Muller, et al., Pharm. Ind., 50(11):1301-1306 (1988) (translation).
Muller, et al., Pharm. Ind., 50(3):370-375 (1988) (translation).
Pohler, Micro-Emulsion Gels Structural Investigations and Galenical Properties (1983) (translation).
Remington's Pharm. Sci. (17th ed.), Microemulsions, Chapter 20:298-299 (1985).
Reymond, et al., Pharm. Res., vol. 5(10):673-676 (1988).
Reymond, et al., Pharm. Res., vol. 5(10):677-679 (1988).
Reymond, In Vitro In Vivi Model for the Absorption of Cyclosporin A (1986) (translation).
Reymond, Pharm. Res., vol. 5(10).
Ritschel, et al., Meth and Find Exp. Clin. Pharmacol., vol. 11(4):281-287 (1989).
Ritschel, Pharm. Res., Suppl. 108 (abstract).
Takada, et al., Int. of Pharmaceutics, vol. 44:107-116 (1988).
Takada, et al., J. Pharm. Res., vol. 3(1):48-51 (1986).
Takada, et al., J. Pharmacobio-Dyn., vol. 11:80-87 (1988).
Takada, et al., J. Pharmacobio-Dyn., vol. 8:320-323 (1985).
Takada, et al., J. Pharmcobio-Dyn., vol. 9:156-160 (1986).
Tarr, et al., J. Pharm. Res., vol. 6(1):40-43 (1989).
Yanagawa, et al., J. Microencapsulation, vol. 6(2):161-164 (1989).
Ziegenmeyer, et al., Acta Pharmaceutical Technologica, vol. 26(4):273-275 (1980) (translation).
Ulmar's Encyclopaedia of Industrial Pharmacy, vol. A9:298-299 and 308-311 (1987).
Carrigan, et al., J. Pharm. Sci., vol. 62:1476-1479 (1973).
Frazer, et al., J. Physiol., vol. 103:306-310 (1944).
Hauer Birgit
Meinzer Armin
Posanski Ulrich
Richter Friedrich
Kishore Gollamudi S.
Novartis AG
Savitsky Thomas R.
Thallemer John D.
LandOfFree
Pharmaceutical compositions comprising cyclosporins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising cyclosporins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising cyclosporins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3824943